DE60024326D1 - Lipide zur stimulierung der immunreaktion - Google Patents

Lipide zur stimulierung der immunreaktion

Info

Publication number
DE60024326D1
DE60024326D1 DE60024326T DE60024326T DE60024326D1 DE 60024326 D1 DE60024326 D1 DE 60024326D1 DE 60024326 T DE60024326 T DE 60024326T DE 60024326 T DE60024326 T DE 60024326T DE 60024326 D1 DE60024326 D1 DE 60024326D1
Authority
DE
Germany
Prior art keywords
lipids
esterified
glycerol
fatty acids
stimulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60024326T
Other languages
English (en)
Other versions
DE60024326T2 (de
Inventor
William Leslie Porter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10867185&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60024326(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of DE60024326D1 publication Critical patent/DE60024326D1/de
Application granted granted Critical
Publication of DE60024326T2 publication Critical patent/DE60024326T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
DE60024326T 1999-12-29 2000-12-20 Lipide zur stimulierung der immunreaktion Expired - Fee Related DE60024326T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9930862 1999-12-29
GBGB9930862.9A GB9930862D0 (en) 1999-12-29 1999-12-29 Immune response stimulation
PCT/GB2000/004890 WO2001049277A2 (en) 1999-12-29 2000-12-20 Immune response modulation

Publications (2)

Publication Number Publication Date
DE60024326D1 true DE60024326D1 (de) 2005-12-29
DE60024326T2 DE60024326T2 (de) 2006-08-17

Family

ID=10867185

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60024326T Expired - Fee Related DE60024326T2 (de) 1999-12-29 2000-12-20 Lipide zur stimulierung der immunreaktion

Country Status (7)

Country Link
US (1) US20020193576A1 (de)
EP (1) EP1282430B1 (de)
AT (1) ATE310527T1 (de)
AU (1) AU2689901A (de)
DE (1) DE60024326T2 (de)
GB (2) GB9930862D0 (de)
WO (1) WO2001049277A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60123603T2 (de) * 2000-06-14 2007-08-16 William Leslie Diss Porter Lipide zur änderung des abwehrsystems
GB0315783D0 (en) * 2003-07-04 2003-08-13 Norferm Da Use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8727834D0 (en) * 1987-11-27 1987-12-31 Imp Cancer Res Tech Process for producing antibodies
GB9822619D0 (en) * 1998-10-19 1998-12-09 Porter William L Immune response stimulation

Also Published As

Publication number Publication date
ATE310527T1 (de) 2005-12-15
WO2001049277A2 (en) 2001-07-12
WO2001049277A3 (en) 2002-11-28
AU2689901A (en) 2001-07-16
EP1282430B1 (de) 2005-11-23
GB9930862D0 (en) 2000-02-16
GB0014438D0 (en) 2000-08-09
EP1282430A2 (de) 2003-02-12
US20020193576A1 (en) 2002-12-19
DE60024326T2 (de) 2006-08-17

Similar Documents

Publication Publication Date Title
ES2111535T3 (es) Procedimiento para la preparacion de esteres glicosidos y composiciones que comprenden esteres glicosidos.
ES2046249T3 (es) Preparaciones aromatizadas con efecto antimicrobiano.
AR027193A1 (es) Una formula mejorada para ninos, un hidrolizado de proteina para uso en tal formula para ninos, y un metodo para la produccion de tal hidrolizado
EP0378936A3 (en) Use of salicylic-acid derivatives in the treatment of aging of the skin
ES2157898T3 (es) Aceites microbianos y usos de los mismos.
MX168000B (es) Complemento dietetico que contiene beta-glucan complemento
ES2013792A6 (es) Una composicion cosmetica a base de ceramidas.
DK1233969T3 (da) Mono- og disaccharridderivater
DK68080A (da) Anvendelse af fuldstaendigt acetylerede monoglycerider til saenkning af forhoejede cholesterinspejl og eller neutralfedtspejl i menneskeblod
ES2025766T3 (es) Un procedimiento para la preparacion de esteres de acidos grasos de polialcolholes.
JPS568320A (en) Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent
WO1999027924A3 (fr) Agnim comme agents anti-inflammatoires dans les tissus superficiels des mammiferes
SE8404930L (sv) Vattenhaltiga kompositioner, som innehaller stabiliserade enzymer
ES2103369T3 (es) Derivados de lanolina como sustancias que aceleran la penetracion y su aplicacion en sustancias farmaceuticas u otras formulaciones que contienen sustancias biologicamente activas.
DE60024326D1 (de) Lipide zur stimulierung der immunreaktion
Tai et al. Bioavailability of a Series of Novel Acylated Ascorbic Acid Derivatives, 6-O-Acyl-2-O-α-D-glucopyranosyl-L-ascorbic Acids, as an Ascorbic Acid…
AU2001264079A1 (en) Lipids for modulating immune response
WO2001028961A3 (en) Method for the direct esterification of sorbitol with fatty acids
DE69000719T2 (de) Hautreinigungsmittel.
DE60328785D1 (de) Langkettige ungesättigte sauerstoffhaltige verbindungen und deren verwendung im therapeutischen, kosmetischen und diätetischen bereich
NO912890L (no) Preparat inneholdende salicylsyre for behandling av hudsykdommer med avskalling.
JPS6426595A (en) Injection containing estradiol derivative
ES2143940B1 (es) Procedimiento de preparacion selectiva de derivados de alfa-hidroxiacidos.
JPS5414583A (en) Cultivation of yeast containing small amount of odd c-number fatty acid
DE2806804A1 (de) Verfahren zur inhibition von lipasen

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee